Management of Nephrotic Syndrome with Comorbidities

Initial Management

The American College of Physicians recommends starting with salt restriction (<2-3 g/day) and fluid restriction to manage anasarca and edema in patients with nephrotic syndrome 1, 2
The European Renal Association recommends starting furosemide at 0.5-2 mg/kg per dose orally up to six times daily (maximum 10 mg/kg per day) based on the degree of edema and diuresis achieved in patients with nephrotic syndrome 2
The National Kidney Foundation suggests considering adding a thiazide diuretic for synergistic effect with loop diuretics in stable patients with nephrotic syndrome 2
The American Society of Nephrology recommends considering albumin infusions only if there are clinical indicators of hypovolemia (oliguria, prolonged capillary refill time, tachycardia, hypotension) rather than based solely on serum albumin levels in patients with nephrotic syndrome 1, 3

The Endocrine Society recommends starting thyroid hormone replacement therapy immediately as urinary loss of thyroxine-binding proteins in nephrotic syndrome worsens hypothyroidism 4
The American Thyroid Association recommends monitoring free T4 and TSH levels more frequently than usual (every 4-6 weeks initially) and adjusting dosage accordingly in patients with hypothyroidism and nephrotic syndrome 4

The American College of Rheumatology recommends screening for secondary causes of nephrotic syndrome, including autoimmune diseases (ANA, complement levels) 5
The Infectious Diseases Society of America recommends screening for infections (HBV, HCV, HIV) in patients with nephrotic syndrome 6
The International Society of Nephrology recommends assessing for thrombotic risk and considering prophylactic anticoagulation if serum albumin <20-25 g/L with additional risk factors (BMI >35 kg/m², immobilization) 7

The National Institute of Diabetes and Digestive and Kidney Diseases recommends considering corticosteroids (prednisone 1 mg/kg/day) for minimal change disease 8
The European Renal Association recommends considering calcineurin inhibitors as first-line therapy for focal segmental glomerulosclerosis (FSGS) given the patient's diabetes 9, 8
The American Society of Nephrology recommends optimizing RAAS blockade with ACE inhibitors or ARBs for diabetic nephropathy 2

The American Heart Association recommends monitoring fluid status, electrolytes, renal function, and blood pressure daily during initial management of patients with nephrotic syndrome 2
The National Kidney Foundation suggests watching for complications of diuretic therapy, including hypokalemia, hyponatremia, and acute kidney injury in patients with nephrotic syndrome 2
The International Society of Nephrology recommends considering thromboprophylaxis if albumin remains <25 g/L with additional risk factors 7

The American Society of Nephrology recommends avoiding high-dose diuretics (>6 mg/kg/day of furosemide) for periods longer than 1 week due to risk of ototoxicity in patients with nephrotic syndrome 2
The Endocrine Society recommends measuring ionized calcium instead of total serum calcium levels in the presence of hypoalbuminemia 4
The European Renal Association recommends considering the potential interaction between immunosuppressive therapy and diabetes management if immunosuppression is initiated 9